1-16 of 16
Charles Foussard
Close
Sort by
Journal Articles

Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90 y-Epratuzumab Tetraxetan Following R-CHOP in Elderly DLBCL Patients: A Lysa Phase II Prospective Trial

Françoise Kraeber-Bodere, MD, PhD, Amandine Pallardy, MD, Steven Le Gouill, Hervé Maisonneuve, MD, Thierry Lamy, MD, Krimo Bouabdallah, MD, Noel Milpied, MD, Henry Jardel, MD, Eric Deconinck, MD, PhD, Nadine Morineau, MD, Charles Foussard, MD, Annie Brion, MD, Remy Gressin, MD, Olivier Tournilhac, MD, PhD, Emmanuel Gyan, MD, PhD, Anne Moreau, MD, Christian Berthou, MD, Francois Dreyfus, Caroline Bodet-Milin, MD, Anne-Laure Cazeau, MD, Etienne Garin, MD, PhD, Jean-Philippe Vuillez, MD, PhD, Loic Campion, MD, Philippe Moreau, MD, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD, Pierre Soubeyran, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 906.
https://doi.org/10.1182/blood.V120.21.906.906
Published: 2012
Journal Articles

High Response Rate and Low Toxicity of Rituximab, Vinorelbine, Ifosfamide, Mitoxantrone and Prednisone Combination for the Treatment of Diffuse Large B Cell Lymphoma In First Relapse: Early Results of the R-NIMP GOELAMS Study.

Emmanuel Gyan, MD, PhD, Delphine Senecal, MD, Philippe Quittet, MD, Charles Foussard, MD, Anne Banos, MD, Steven Le Gouill, MD, PhD, Charles Dauriac, MD, Julie Léger, Jean Fontan, MD, Diane Damotte, MD, Hervé Maisonneuve, MD, Magda Alexis, MD, Francois Dreyfus, MD, PhD, Stéphane Courby, MD, Jean-Louis Dutel, MD, Olivier Tournilhac, MD, PhD, Kamel Laribi, MD, Philippe Solal-Céligny, MD, Annick Le Pourhiet-Le Mevel, MD, Nina Arakelyan, MD, Henry Jardel, MD, Remy Gressin, MD
Journal: Blood
Blood (2010) 116 (21): 2796.
https://doi.org/10.1182/blood.V116.21.2796.2796
Published: 2010
Journal Articles

No Benefit of First-Line Rituximab (R) - High-Dose Therapy (R-HDT) Over R-CHOP14 for Young Adults with Diffuse Large B-Cell Lymphoma. Preliminary Results of the GOELAMS 075 Prospective Multicentre Randomized Trial

Noel-Jean Milpied, MD, Steven Legouill, Thierry Lamy, Vincent Delwail, Remy Gressin, MD, Denis Guyotat, Gandhi Damaj, MD, Charles Foussard, MD, Philippe Quittet, MD, Herve Maisonneuve, MD, Eric Deconinck, Francois Dreyfus, MD, Emmanuel Gyan, MD, PhD, Laurent Sutton, Nadine Morineau, MD, Magda Alexis, MD, Frederic Perry, Mathieu Sauvezie
Journal: Blood
Blood (2010) 116 (21): 685.
https://doi.org/10.1182/blood.V116.21.685.685
Published: 2010
Journal Articles

Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90Y Epratuzumab Tetraxetan Following R-CHOP In Elderly DLBCL Patients

Françoise kraeber-Bodere, Hervé Maisonneuve, MD, Thierry Lamy, Steven Le Gouill, Eric Deconninck, MD, Amandine Pallardy, Caroline bodet-Milin, Noel Milpied, MD, Nadine Morineau, MD, Charles Foussard, MD, Thomas Gastinne, Remy Gressin, MD, Olivier Tournilhac, MD, PhD, Emmanuel Gyan, MD, PhD, Anne Moreau, Alain Faivre-Chauvet, Anne-Laure Cazeau, Etienne Garin, Jean-Philippe Vuillez, Jean-François Chatal, Jean-Luc Harousseau, Philippe Moreau, William Wegener, MD, PhD, David Goldenberg, Pierre Soubeyran, MD
Journal: Blood
Blood (2010) 116 (21): 2875.
https://doi.org/10.1182/blood.V116.21.2875.2875
Published: 2010
Journal Articles

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years

Clinical Trials & Observations
Emmanuel Gyan, Charles Foussard, Philippe Bertrand, Patrick Michenet, Steven Le Gouill, Christian Berthou, Hervé Maisonneuve, Vincent Delwail, Rémi Gressin, Philippe Quittet, Jean-Pierre Vilque, Bernard Desablens, Jérôme Jaubert, Jean-François Ramée, Nina Arakelyan, Antoine Thyss, Cécile Moluçon-Chabrot, Roselyne Delépine, Noël Milpied, Philippe Colombat, Eric Deconinck
Journal: Blood
Blood (2009) 113 (5): 995–1001.
https://doi.org/10.1182/blood-2008-05-160200
Published: 2009
Journal Articles

Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study

Clinical Trials & Observations
Gilles Salles, Nicolas Mounier, Sophie de Guibert, Franck Morschhauser, Chantal Doyen, Jean-François Rossi, Corinne Haioun, Pauline Brice, Béatrice Mahé, Reda Bouabdallah, Bruno Audhuy, Christophe Ferme, Caroline Dartigeas, Pierre Feugier, Catherine Sebban, Luc Xerri, Charles Foussard
Journal: Blood
Blood (2008) 112 (13): 4824–4831.
https://doi.org/10.1182/blood-2008-04-153189
Published: 2008
Includes: Supplemental data
Journal Articles

Autologous Stem Cell Transplantation (auto-SCT) as the Treatment of Choice for Follicular Lymphoma Patients in First Relapse: Final Analysis of the Outcome of 175 Patients Treated in the GELA/GOELAMS FL 2000 Study

Steven Le Gouill, MD, PhD, Sophie De Guibert, Christelle Volteau, Marion Fournier, Franck Morschhauser, Chantal Doyen, Pauline Brice, Corinne Haioun, Charles Foussard, Gilles Andre Salles, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 773.
https://doi.org/10.1182/blood.V112.11.773.773
Published: 2008
Journal Articles

Rituximab Combined with Chemotherapy and Interferon in Follicular Lymphoma Patients: Final Analysis of the GELA-GOELAMS FL2000 Study with a 5-Year Follow-Up.

Gilles Andre Salles, MD, PhD, Nicolas Mounier, MD, PhD, Sophie de Guibert, MD, Franck Morschhauser, MD, Chantal Doyen, MD, Jean-Francois Rossi, MD, PhD, Corinne Haioun, MD, Pauline Brice, MD, Béatrice Mahé, MD, Reda Bouabdallah, MD, Bruno Audhuy, MD, Christophe Ferme, MD, Caroline Dartigeas, MD, Pierre Feugier, MD, Catherine Sebban, MD, Luc Xerri, MD, PhD, Charles Foussard, MD
Journal: Blood
Blood (2007) 110 (11): 792.
https://doi.org/10.1182/blood.V110.11.792.792
Published: 2007
Journal Articles

The Poor Prognosis Value of High Intra-Tumoral Macrophages Counts in Follicular Lymphoma Patients Requires Selection of Appropriate Cut-Off and Can Be Circumvented by Rituximab Therapy.

Danielle Canioni, Gilles Salles, Nicolas Mounier, Nicole Brousse, Marie Keuppens, Frank Morchauser, Marion Fournier, Thierry Lamy, Marie-Christine Rousselet, Charles Foussard, Luc Xerri
Journal: Blood
Blood (2006) 108 (11): 822.
https://doi.org/10.1182/blood.V108.11.822.822
Published: 2006
Journal Articles

Single Treatment with Rituximab Monotherapy for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with Extended Follow-Up (F/Up) of 7 Years.

Philippe Colombat, Nicole Brousse, Franck Morschhauser, Patricia Franchi-Rezgui, Pierre Soubeyran, Vincent Delwail, Eric Deconinck, Corinne Haioun, Charles Foussard, Catherine Sebban, Herve Tilly, Noel-Jean Milpied, Francois Boue, Jean-Michel Karsenti, Pierre Lederlin, Albert Najman, Catherine Thieblemont, Delphine Moreau, Loic Bergougnoux, Gilles Andre Salles, Philippe Solal-Celigny
Journal: Blood
Blood (2006) 108 (11): 486.
https://doi.org/10.1182/blood.V108.11.486.486
Published: 2006
Journal Articles

The VIP-ABVD Regimen Is Not Superior to the CHOP 21 for the Treatment of Non Epidermotropic Peripheral T Cell Lymphoma. Final Results of the “LTP95” Protocol of the GOELAMS.

Remy Gressin, MD, Michel Peoch, MD, Eric Deconinck, MD, Philippe Casassus, MD, Bernard Desablens, MD, Delphine Senecal, MD, Philippe Quitet, MD, Jean Pierre Vilque, MD, Charles Foussard, MD, Houchingue Eghbali, MD, Jerome Jaubert, MD, Olivier Tournilhac, MD, Virginie Lucas, MD, Vincent Delwail, MD, Bachera Choufi, MD, Antoine Thyss, MD, Francoise Huguet, MD, Frederic Maloisel, MD, Bruno Richard, MD, Noel-Jean Milpied, MD, Philippe Colombat, MD
Journal: Blood
Blood (2006) 108 (11): 2464.
https://doi.org/10.1182/blood.V108.11.2464.2464
Published: 2006
Journal Articles

Preliminary Results of a Prospective Randomized Study Comparing First Line Conventional Therapy Versus High Dose Therapy with Autologous CD34+ Purified Progenitor Cell Support in B CLL Patients with B and C Binet Stages: The GOELAMS LLC98 Study.

Annie Brion, Beatrice Mahe, Brigitte Kolb, Bernard Audhuy, Philippe Colombat, Herve Maisoneuve, Charles Foussard, Alain Bureau, Pierre Feugier
Journal: Blood
Blood (2005) 106 (11): 152.
https://doi.org/10.1182/blood.V106.11.152.152
Published: 2005
Journal Articles

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS

Clinical Trials & Observations
Eric Deconinck, Charles Foussard, Noel Milpied, Philippe Bertrand, Patrick Michenet, Pascale Cornillet-LeFebvre, Martine Escoffre-Barbe, Herve Maisonneuve, Vincent Delwail, Remy Gressin, Eric Legouffe, Jean-Pierre Vilque, Bernard Desablens, Jerome Jaubert, Jean-François Ramee, Arash Jenabian, Antoine Thyss, Annick Le Pourhiet-Le Mevel, Philippe Travade, Roselyne Delepine, Philippe Colombat, GOELAMS
Journal: Blood
Blood (2005) 105 (10): 3817–3823.
https://doi.org/10.1182/blood-2004-10-3920
Published: 2005
Journal Articles

Single 4-Dose Rituximab Treatment for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with a Follow-Up (F/Up) of at Least 5 Years.

Philippe Solal-Celigny, MD, PhD, Gilles Andre Salles, MD, PhD, Nicole Brousse, MD, Patricia Franchi-Rezgui, MD, Pierre Soubeyran, MD, PhD, Vincent Delwail, MD, Eric Deconinck, MD, Corinne Haioun, MD, PhD, Charles Foussard, MD, Catherine Sebban, MD, Herve Tilly, MD, PhD, Noel-Jean Milpied, MD, PhD, Francois Boue, MD, Jean-Michel Karsenti, MD, Pierre Lederlin, MD, PhD, Albert Najman, MD, Catherine Thieblemont, MD, PhD, Franck Morschhauser, MD, Nathalie Berriot-Varoqueaux, MD, PhD, Loic Bergougnoux, Philippe Colombat, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 585.
https://doi.org/10.1182/blood.V104.11.585.585
Published: 2004
Journal Articles

Rituximab Added αIFN+CHVP Improves the Outcome of Follicular Lymphoma Patients with a High Tumor Burden: to First Analysis of the GELA-GOELAMS FL-2000 Randomized Trial in 359 Patients.

Gilles Andre Salles, MD, PhD, Charles Foussard, MD, Mounier Nicolas, MD, PhD, Morschhauser Franck, MD, Doyen Chantal, MD, Lamy Thierry, MD, Haioun Corinne, MD, Brice Pauline, MD, Bouabdallah Reda, MD, Rossi Jean-François, MD, PhD, Audhuy Bruno, MD, Fermé Christophe, MD, Mahe Béatrice, MD, Feugier Pierre, MD, Sebban Catherine, MD, Colombat Philippe, MD, Xerri Luc, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 160.
https://doi.org/10.1182/blood.V104.11.160.160
Published: 2004
Journal Articles

Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation

Clinical Trials & Observations
Philippe Colombat, Gilles Salles, Nicole Brousse, Pitahey Eftekhari, Piere Soubeyran, Vincent Delwail, Eric Deconinck, Corinne Haı̈oun, Charles Foussard, Catherine Sebban, Astasia Stamatoullas, Noël Milpied, François Boué, Bruno Taillan, Pierre Lederlin, Albert Najman, Catherine Thièblemont, François Montestruc, Anne Mathieu-Boué, Aziz Benzohra, Philippe Solal-Céligny
Journal: Blood
Blood (2001) 97 (1): 101–106.
https://doi.org/10.1182/blood.V97.1.101
Published: 2001